Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10076519 Substituted pyridazines as skeletal muscle modulators

Patent 10076519 was granted and assigned to Cytokinetics on September, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Cytokinetics

Current Assignee

Cytokinetics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100765190

Patent Inventor Names

Alex R. Muci0

Antonio Romero0

Bradley P. Morgan0

Chihyuan Chuang0

Gustave Bergnes0

Jeff Gardina0

Jeffrey Warrington0

Luke W. Ashcraft0

...

Date of Patent

September 18, 2018

Patent Application Number

154632880

Date Filed

March 20, 2017

Patent Citations Received

‌

US Patent 11369565 Amino-pyrimidine skeletal muscle modulators

‌

US Patent 11021708 Methods and compositions for modulating splicing

‌

US Patent 11603531 Methods and compositions for modulating splicing

‌

US Patent 11326165 Methods and compositions for modulating splicing

‌

US Patent 11434489 Methods and compositions for modulating splicing

‌

US Patent 11981644 Bicyclic 1,4-diazepanones and therapeutic uses thereof

‌

US Patent 11964971 Methods and compositions for modulating splicing

‌

US Patent 10272030 Amino-pyrimidine skeletal muscle modulators

...

Patent Primary Examiner

‌

Douglas M Willis

Patent abstract

Provided are compounds of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10076519 Substituted pyridazines as skeletal muscle modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API